A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
about
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation.A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinomaThe FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.
P2860
Q38378485-C12EDE83-8636-4A5C-BEA5-1D244ACB614EQ38865611-6AD45E4B-E417-4E33-BD21-683607227C7CQ38883187-E43BB092-4448-48C5-A1AF-EEF61DF71429Q39146689-DB438E11-3ABC-4EF4-9002-4485DCBE5B91Q41239578-A68DB90F-CC37-465A-8583-BED15F484A43Q42014310-6FCD12E0-F590-477B-BDB5-4BA8CC09F886Q48150834-C428DD9F-9B48-49BD-9DA3-E7F218DC72F8Q49592440-84F2DEBC-54D6-413A-BE8A-BAD933720675
P2860
A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@ast
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@en
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@nl
type
label
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@ast
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@en
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@nl
prefLabel
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@ast
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@en
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@nl
P2093
P2860
P1476
A Phase II trial of axitinib i ...... etic/pharmacodynamic analyses.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-014-2604-8
P577
2014-10-15T00:00:00Z
P5875
P6179
1048029020